CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis

Arthritis Research and Therapy

Volumn 17, Issue 1, 2015, Pages

  Karpus, Olga N ^a   Kiener, Hans P ^b   Niederreiter, Birgit ^b   Yilmaz Elis, A Seda ^c   van der Kaa, Jos ^c   Ramaglia, Valeria ^a   Arens, Ramon ^c   Smolen, Josef S ^b   Botto, Marina ^d   Tak, Paul P ^a,e   Verbeek, J Sjef ^c   Hamann, Jörg ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENT COMPONENT C3; DECAY ACCELERATING FACTOR; PHOSPHOLIPASE C; ANTIGEN ANTIBODY COMPLEX; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; COLLAGEN FIBER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IMMUNE COMPLEX MEDIATED ARTHRITIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SYNOVIOCYTE; SYNOVIUM; ANIMAL; ARTHRITIS, RHEUMATOID; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD55; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COLLAGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SYNOVIAL MEMBRANE;

EID: 84924330106     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-015-0518-4     Document Type: Article

References (52)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356-61.
2. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev. 2008;223:252-70.
3. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233-55.
4. Kiener HP, Lee DM, Agarwal SK, Brenner MB. Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro. Am J Pathol. 2006;168:1486-99.
5. Kiener HP, Watts GF, Cui Y, Wright J, Thornhill TS, Skold M, et al. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. Arthritis Rheum. 2010;62:742-52.
6. Stevens CR, Mapp PI, Revell PA. A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int. 1990;10:103-6.
7. Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 1999;42:650-8.
8. Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol. 1989;7:35-58.
9. Song WC. Complement regulatory proteins and autoimmunity. Autoimmunity. 2006;39:403-10.
10. Hamann J, Vogel B, van Schijndel GM, van Lier RA. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med. 1996;184:1185-9.
11. Langenhan T, Aust G, Hamann J. Sticky signaling-adhesion class G protein-coupled receptors take the stage. Sci Signal. 2013. 6:re3.
12. Kop EN, Kwakkenbos MJ, Teske GJ, Kraan MC, Smeets TJ, Stacey M, et al. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Arthritis Rheum. 2005;52:442-50.
13. Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, et al. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. Arthritis Rheum. 2010;62:1036-42.
14. Karpus ON, Heutinck KM, Wijnker PJ, Tak PP, Hamann J. Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts. PLoS One. 2012;7:e35606.
15. Gerlag DM, Tak PP. How to perform and analyse synovial biopsies. Best Pract Res Clin Rheumatol. 2009;23:221-32.
16. The 2010 ACR-EULAR classification criteria for rheumatoid arthritis. http://www.rheumatology.org
17. Larsen H, Muz B, Khong TL, Feldmann M, Paleolog EM. Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA. Arthritis Res Ther. 2012;14:R180.
18. Boross P, Arandhara VL, Martin-Ramirez J, Santiago-Raber ML, Carlucci F, Flierman R, et al. The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility. J Immunol. 2011;187:1304-13.
19. Boross P, van Lent PL, Martin-Ramirez J, van der Kaa J, Mulder MH, Claassens JW, et al. Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII. J Immunol. 2008;180:5083-91.
20. Image processing and analysis in Java. http://rsb.info.nih.gov/ij/
21. Terstappen LW, Nguyen M, Lazarus HM, Medof ME. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation. J Leukoc Biol. 1992;52:652-60.
22. Louis NA, Hamilton KE, Kong T, Colgan SP. HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. FASEB J. 2005;19:950-9.
23. Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, Bresnihan B, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis. 2010;69:1389-95.
24. Montes GS. Structural biology of the fibres of the collagenous and elastic systems. Cell Biol Int. 1996;20:15-27.
25. Ushiki T. Collagen fibers, reticular fibers and elastic fibers: a comprehensive understanding from a morphological viewpoint. Arch Histol Cytol. 2002;65:109-26.
26. Davitz MA, Low MG, Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC): selective modification of a complement regulatory protein. J Exp Med. 1986;163:1150-61.
27. Hindmarsh EJ, Marks RM. Decay-accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C. Eur J Immunol. 1998;28:1052-62.
28. Gelderman KA, Zijlmans HJ, Vonk MJ, Gorter A. CD55 expression patterns on intestinal neuronal tissue are divergent from the brain. Gut. 2004;53:507-13.
29. Puchtler H, Waldrop FW. Silver impregnation methods for reticulum fibers and reticulin: a re-investigation of their origins and specificity. Histochemistry. 1978;57:177-87.
30. Van Vliet E, Melis M, Foidart JM, Van Ewijk W. Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J Histochem Cytochem. 1986;34:883-90.
31. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med. 2004;200:783-95.
32. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, Gonzalez SF, et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol. 2012;13:499-510.
33. Vetto AA, Mannik M, Zatarain-Rios E, Wener MH. Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol Int. 1990;10:13-9.
34. Konttinen YT, Ceponis A, Meri S, Vuorikoski A, Kortekangas P, Sorsa T, et al. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis. 1996;55:888-94.
35. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002;16:157-68.
36. Monach PA, Verschoor A, Jacobs JP, Carroll MC, Wagers AJ, Benoist C, et al. Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model. Arthritis Rheum. 2007;56:2968-74.
37. Sadik CD, Kim ND, Iwakura Y, Luster AD. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgammaR signaling. Proc Natl Acad Sci U S A. 2012;109:E3177-85.
38. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326:1216-9.
39. Scott DL, Salmon M, Walton KW. Reticulin and its related structural connective tissue proteins in the rheumatoid synovium. Histopathology. 1984;8:469-79.
40. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med. 1987;165:848-64.
41. Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol. 1996;149:129-42.
42. Spendlove I, Li L, Carmichael J, Durrant LG. Decay accelerating factor (CD55): a target for cancer vaccines? Cancer Res. 1999;59:2282-6.
43. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244-79.
44. Hindmarsh EJ, Marks RM. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J Immunol. 1998;160:6128-36.
45. Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand O, Harboe M. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum. 1986;29:715-21.
46. Swaak AJ, van Rooyen A, Planten O, Han H, Hattink O, Hack E. An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin Rheumatol. 1987;6:350-7.
47. Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol. 1991;20:183-9.
48. Stuart JM, Dixon FJ. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983;158:378-92.
49. Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol. 2002;3:360-5.
50. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med. 2012;18:1401-6.
51. Godau J, Heller T, Hawlisch H, Trappe M, Howells E, Best J, et al. C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol. 2004;173:3437-45.
52. Ricklin D, Reis ES, Lambris JD. A sweet spot to control complement-induced inflammation. Nat Med. 2012;18:1340-1.